Organization Profile

Related Organization(s)

You just read:

CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema

News provided by

CSL Behring

May 03, 2012, 15:39 ET